Related Experiment Video
Updated: Jun 25, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Decreasing childhood pertussis infection through vaccination of the elderly
Tanner W Higginbotham1, Kevin W Cleveland
1Idaho State University College of Pharmacy, Pocatello, ID 83209-8092, USA.
Insights
Reported pertussis (whooping cough) cases are rising in infants and adolescents, alongside infant deaths. Vaccinating older adults could prevent transmission to children, but current vaccines aren
Area of Science:
- * Public Health
- * Infectious Diseases
- * Immunology
Background:
- * Increasing pertussis (whooping cough) incidence observed in infants and adolescents.
- * Rising infant mortality rates linked to pertussis infections caused by Bordetella pertussis.
- * Adults, particularly those aged 65 and older, are significant vectors for pertussis transmission due to waning immunity.
Purpose of the Study:
- * To evaluate the potential public health benefit of recommending the Tdap vaccine for individuals aged 64 and older.
- * To assess the role of older adults in the transmission cycle of pertussis to vulnerable pediatric populations.
Main Methods:
- * Review of epidemiological data on pertussis incidence and mortality in infants and adolescents.
- * Analysis of the role of adult populations, specifically those 65 years and older, as transmission vectors.
- * Examination of evidence regarding waning immunity post-infection or vaccination in adults.
Main Results:
- * Pertussis cases and associated infant deaths are increasing.
- * Older adults represent a substantial pool for pertussis transmission.
- * Immunity wanes in adults after infection or vaccination, increasing susceptibility and transmission potential.
Conclusions:
- * Recommending the Tdap vaccine for individuals 64 years and older could significantly benefit public health by reducing pertussis transmission to children.
- * Current Tdap vaccines are not licensed for individuals over 65, and no off-label recommendations exist from the CDC's Advisory Committee on Immunization Practices for this age group.
Abstract:
Reported cases of pertussis (also known as whooping cough) are increasing among infants and adolescents. This rise parallels the number of reported infant deaths associated with pertussis infection, which is caused by the gram-positive bacterium Bordetella pertussis. Adults are a significant vector for transmission of pertussis to children, and people 65 years of age and older make up a substantial portion of this potential transmission pool. Evidence exists of waning immunity in the adult population after either infection or vaccination. A recommendation for the use of a pertussis-containing vaccine (Tdap) in persons 64 years of age and older would be of considerable benefit to the public in preventing some transmission of pertussis to children. Neither of the two Tdap vaccines (pediatric or adult) is licensed for persons older than 65 years of age, and the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention gives no off-label recommendation for use of Tdap in patients 65 years of age or older.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Vaccinations
Poliomyelitis
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox
Vaccines
Respiratory Syncytial Virus Disease